4.7 Article

Effect of a Fiber D-Limonene-Enriched Food Supplement on Intestinal Microbiota and Metabolic Parameters of Mice on a High-Fat Diet

期刊

PHARMACEUTICS
卷 13, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/pharmaceutics13111753

关键词

D-Limonene; high fat diet (HFD); intestinal microbiota; obesity

资金

  1. University of Bologna
  2. Targeting Gut Disease Srl, a Spin-off of the University of Bologna

向作者/读者索取更多资源

Studies have shown that D-Limonene can improve metabolic parameters in obese mice via various mechanisms, including modulation of intestinal microbiota. Administering a food supplement containing D-Limonene adsorbed on dietary fibers to mice on a high-fat diet led to decreased weight gain and improved metabolic profile, highlighting the potential non-toxic and effective use of this supplement in combating obesity.
Several studies showed that D-Limonene can improve metabolic parameters of obese mice via various mechanisms, including intestinal microbiota modulation. Nevertheless, its effective doses often overcome the acceptable daily intake, rising concerns about toxicity. In this study we administered to C57BL/6 mice for 84 days a food supplement based on D-Limonene, adsorbed on dietary fibers (FLS), not able to reach the bloodstream, to counteract the metabolic effects of a high-fat diet (HFD). Results showed that daily administration of D-Limonene (30 and 60 mg/kg body weight) for 84 days decreased the weight gain of HFD mice. After 84 days we observed a statistically significant difference in weight gain in the group of mice receiving the higher dose of FLS compared to HFD mice (35.24 & PLUSMN; 4.56 g vs. 40.79 & PLUSMN; 3.28 g, p < 0.05). Moreover, FLS at both doses tested was capable of lowering triglyceridemia and also fasting glycemia at the higher dose. Some insights on the relevant fatty acid changes in hepatic tissues were obtained, highlighting the increased polyunsaturated fatty acid (PUFA) levels even at the lowest dose. FLS was also able to positively modulate the gut microbiota and prevent HFD-associated liver steatosis in a dose-dependent manner. These results demonstrate that FLS at these doses can be considered non-toxic and could be an effective tool to counteract diet-induced obesity and ameliorate metabolic profile in mice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据